Literature DB >> 22153987

Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy.

E Somers1, Z Stencel, T M Wishart, T H Gillingwater, S H Parson.   

Abstract

Spinal muscular atrophy (SMA) is traditionally described and characterised as a disease of the neuromuscular system. Recently, the vascular system has been implicated in SMA pathogenesis, but there are no reports on whether this impacts on skeletal muscle microvasculature. Using an established mouse model of severe SMA (Smn(-/-);SMN2(+/+)), we examined the capillary bed in three different skeletal muscles using quantitative imaging and western blotting in late symptomatic mice (P5). We found a dramatic (45%) decrease in the density of the capillary bed in all muscles examined compared to littermate controls at early and late symptomatic time points, and reduced expression of a key endothelial protein, PECAM-1. In addition, capillary calibre was increased by 50% in SMA mice while ramification of capillaries into muscle was reduced. Investigation of earlier developmental time points revealed identical changes at an early symptomatic time point (P3), but significantly, no difference at a pre-symptomatic time point (P1). These changes are likely to have considerable impact on the ability of the muscle capillary bed to deliver oxygen and remove metabolites from muscle and may therefore contribute to pathogenesis in SMA.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22153987     DOI: 10.1016/j.nmd.2011.10.021

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  29 in total

1.  Decreased function of survival motor neuron protein impairs endocytic pathways.

Authors:  Maria Dimitriadi; Aaron Derdowski; Geetika Kalloo; Melissa S Maginnis; Patrick O'Hern; Bryn Bliska; Altar Sorkaç; Ken C Q Nguyen; Steven J Cook; George Poulogiannis; Walter J Atwood; David H Hall; Anne C Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-11       Impact factor: 11.205

2.  SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy.

Authors:  Marie-Therese Khairallah; Jacob Astroski; Sarah K Custer; Elliot J Androphy; Craig L Franklin; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

3.  Motor neuron biology and disease: A current perspective on infantile-onset spinal muscular atrophy.

Authors:  Narendra N Jha; Jeong-Ki Kim; Umrao R Monani
Journal:  Future Neurol       Date:  2018-07-06

4.  Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585.

Authors:  Julia Schreml; Markus Riessland; Mario Paterno; Lutz Garbes; Kristina Roßbach; Bastian Ackermann; Jan Krämer; Eilidh Somers; Simon H Parson; Raoul Heller; Albrecht Berkessel; Anja Sterner-Kock; Brunhilde Wirth
Journal:  Eur J Hum Genet       Date:  2012-10-17       Impact factor: 4.246

Review 5.  SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities.

Authors:  Catherine E Dominguez; David Cunningham; Dawn S Chandler
Journal:  Hum Genet       Date:  2017-08-29       Impact factor: 4.132

Review 6.  SMN-inducing compounds for the treatment of spinal muscular atrophy.

Authors:  Monique A Lorson; Christian L Lorson
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

Review 7.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610

8.  The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse models.

Authors:  Rocky G Gogliotti; Herminio Cardona; Jasbir Singh; Sophie Bail; Carina Emery; Nancy Kuntz; Michael Jorgensen; Madel Durens; Bing Xia; Courtenay Barlow; Christopher R Heier; Heather L Plasterer; Vincent Jacques; Megerditch Kiledjian; Jill Jarecki; James Rusche; Christine J DiDonato
Journal:  Hum Mol Genet       Date:  2013-06-04       Impact factor: 6.150

9.  Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy.

Authors:  Thomas M Wishart; Chantal A Mutsaers; Markus Riessland; Michell M Reimer; Gillian Hunter; Marie L Hannam; Samantha L Eaton; Heidi R Fuller; Sarah L Roche; Eilidh Somers; Robert Morse; Philip J Young; Douglas J Lamont; Matthias Hammerschmidt; Anagha Joshi; Peter Hohenstein; Glenn E Morris; Simon H Parson; Paul A Skehel; Thomas Becker; Iain M Robinson; Catherina G Becker; Brunhilde Wirth; Thomas H Gillingwater
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

10.  Restoration of SMN to Emx-1 expressing cortical neurons is not sufficient to provide benefit to a severe mouse model of Spinal Muscular Atrophy.

Authors:  Alexander S Taylor; Jacqueline J Glascock; Ferrill F Rose; Cathleen Lutz; Christian L Lorson
Journal:  Transgenic Res       Date:  2013-03-20       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.